250
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber

, , , , &
Pages 1833-1840 | Accepted 24 Apr 2008, Published online: 28 May 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kazuhiro Hashiguchi, Sho Kanzaki, Ken-ichiro Wakabayashi, Nobuaki Tanaka, Kayoko Kawashima, Kiyochika Suematsu, Shoji Tokunaga, Kaoru Ogawa & Kimihiro Okubo. (2013) Efficacy of fluticasone furoate nasal spray and levocetirizine in patients with Japanese cedar pollinosis subjected to an artificial exposure chamber. Journal of Drug Assessment 2:1, pages 94-105.
Read now
Elisa Villa, Maria Sandra Magnoni, Dino Micheli & Giorgio Walter Canonica. (2011) A review of the use of fluticasone furoate since its launch. Expert Opinion on Pharmacotherapy 12:13, pages 2107-2117.
Read now

Articles from other publishers (21)

Sarah K. Wise, Cecelia Damask, Lauren T. Roland, Charles Ebert, Joshua M. Levy, Sandra Lin, Amber Luong, Kenneth Rodriguez, Ahmad R. Sedaghat, Elina Toskala, Jennifer Villwock, Baharudin Abdullah, Cezmi Akdis, Jeremiah A. Alt, Ignacio J. Ansotegui, Antoine Azar, Fuad Baroody, Michael S. Benninger, Jonathan Bernstein, Christopher Brook, Raewyn Campbell, Thomas Casale, Mohamad R. Chaaban, Fook Tim Chew, Jeffrey Chambliss, Antonella Cianferoni, Adnan Custovic, Elizabeth Mahoney Davis, John M. DelGaudio, Anne K. Ellis, Carrie Flanagan, Wytske J. Fokkens, Christine Franzese, Matthew Greenhawt, Amarbir Gill, Ashleigh Halderman, Jens M. Hohlfeld, Cristoforo Incorvaia, Stephanie A. Joe, Shyam Joshi, Merin Elizabeth Kuruvilla, Jean Kim, Adam M. Klein, Helene J. Krouse, Edward C. Kuan, David Lang, Desiree Larenas‐Linnemann, Adrienne M. Laury, Matt Lechner, Stella E. Lee, Victoria S. Lee, Patricia Loftus, Sonya Marcus, Haidy Marzouk, Jose Mattos, Edward McCoul, Erik Melen, James W. Mims, Joaquim Mullol, Jayakar V. Nayak, John Oppenheimer, Richard R. Orlandi, Katie Phillips, Michael Platt, Murugappan RamanathanJrJr, Mallory Raymond, Chae‐Seo Rhee, Sietze Reitsma, Matthew Ryan, Joaquin Sastre, Rodney J. Schlosser, Theodore A. Schuman, Marcus S. Shaker, Aziz Sheikh, Kristine A. Smith, Michael B. Soyka, Masayoshi Takashima, Monica Tang, Pongsakorn Tantilipikorn, Malcolm B. Taw, Jody Tversky, Matthew A. Tyler, Maria C. Veling, Dana Wallace, De Yun Wang, Andrew White & Luo Zhang. (2023) International consensus statement on allergy and rhinology: Allergic rhinitis – 2023. International Forum of Allergy & Rhinology 13:4, pages 293-859.
Crossref
Yousef El-Hefny, Bassam Mahboub, Ayman Al-Fraihat, Ricardo Persaud, Abdul Juratli, Faheem Tadros, Abdul Aljassim, Anastasios Hantzakos, Bernard Hoffmann, Khairullah Alabdali, Khalid Elmesallamy, Mahdi Shkoukani, Taher Mohamed & Mohamed Alrakhawy. (2022) An Algorithm Recommendation for Management of Allergic Rhinitis in the United Arab Emirates: A Consensus Statement from an Expert Panel. New Emirates Medical Journal 3:2.
Crossref
Oliver Pfaar, Karl‐Christian Bergmann, Sergio Bonini, Enrico Compalati, Nathalie Domis, Frédéric de Blay, Pieter‐Jan de Kam, Philippe Devillier, Stephen R. Durham, Anne K. Ellis, Alina Gherasim, Laura Haya, Jens M. Hohlfeld, Friedrich Horak, Tomohisa Iinuma, Robert L. Jacobs, Henrik Hugo Jacobi, Marek Jutel, Susanne Kaul, Suzanne Kelly, Ludger Klimek, Mark Larché, Patrick Lemell, Vera Mahler, Hendrik Nolte, Yoshitaka Okamoto, Piyush Patel, Ronald L. Rabin, Cynthia Rather, Angelika Sager, Anne Marie Salapatek, Torben Sigsgaard, Alkis Togias, Christoph Willers, William H. Yang, René Zieglmayer, Torsten Zuberbier & Petra Zieglmayer. (2021) Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report. Allergy 76:12, pages 3589-3612.
Crossref
Lubnaa Hossenbaccus, Lisa M. Steacy, Terry Walker & Anne K. Ellis. (2020) Utility of Environmental Exposure Unit Challenge Protocols for the Study of Allergic Rhinitis Therapies. Current Allergy and Asthma Reports 20:8.
Crossref
Ludger Klimek, Claus Bachert, Oliver Pfaar, Sven Becker, Thomas Bieber, Randolf Brehler, Roland Buhl, Ingrid Casper, Adam Chaker, Wolfgang Czech, Jörg Fischer, Thomas Fuchs, Michael Gerstlauer, Karl Hörmann, Thilo Jakob, Kirsten Jung, Matthias V. Kopp, Vera Mahler, Hans Merk, Norbert Mülleneisen, Katja Nemat, Uta Rabe, Johannes Ring, Joachim Saloga, Wolfgang Schlenter, Carsten Schmidt-Weber, Holger Seyfarth, Annette Sperl, Thomas Spindler, Petra Staubach, Sebastian Strieth, Regina Treudler, Christian Vogelberg, Andrea Wallrafen, Wolfgang Wehrmann, Holger Wrede, Torsten Zuberbier, Anna Bedbrook, Giorgio W. Canonica, Victoria Cardona, Thomas B. Casale, Wienczylawa Czarlewski, Wytske J. Fokkens, Eckard Hamelmann, Peter W. Hellings, Marek Jutel, Désirée Larenas-Linnemann, Joaquim Mullol, Nikolaos G. Papadopoulos, Sanna Toppila-Salmi, Thomas Werfel & Jean Bousquet. (2019) ARIA guideline 2019: treatment of allergic rhinitis in the German health system. Allergo Journal International 28:7, pages 255-276.
Crossref
Ludger Klimek, Claus Bachert, Oliver Pfaar, Sven Becker, Thomas Bieber, Randolf Brehler, Roland Buhl, Ingrid Casper, Adam Chaker, Wolfgang Czech, Jörg Fischer, Thomas Fuchs, Michael Gerstlauer, Karl Hörmann, Thilo Jakob, Kirsten Jung, Matthias V. Kopp, Vera Mahler, Hans Merk, Norbert Mülleneisen, Katja Nemat, Uta Rabe, Johannes Ring, Joachim Saloga, Wolfgang Schlenter, Carsten Schmidt-Weber, Holger Seyfarth, Annette Sperl, Thomas Spindler, Petra Staubach, Sebastian Strieth, Regina Treudler, Christian Vogelberg, Andrea Wallrafen, Wolfgang Wehrmann, Holger Wrede, Torsten Zuberbier, Anna Bedbrook, Giorgio W. Canonica, Victoria Cardona, Thomas B. Casale, Wienczylawa Czarlewski, Wytske J. Fokkens, Eckard Hamelmann, Peter W. Hellings, Marek Jutel, Désirée Larenas-Linnemann, Joaquim Mullol, Nikolaos G. Papadopoulos, Sanna Toppila-Salmi, Thomas Werfel & Jean Bousquet. (2019) ARIA-Leitlinie 2019: Behandlung der allergischen Rhinitis im deutschen Gesundheitssystem. Allergo Journal 28:7, pages 20-46.
Crossref
Sarah K. Wise, Sandra Y. Lin, Elina Toskala, Richard R. Orlandi, Cezmi A. Akdis, Jeremiah A. Alt, Antoine Azar, Fuad M. Baroody, Claus Bachert, G. Walter Canonica, Thomas Chacko, Cemal Cingi, Giorgio Ciprandi, Jacquelynne Corey, Linda S. Cox, Peter Socrates Creticos, Adnan Custovic, Cecelia Damask, Adam DeConde, John M. DelGaudio, Charles S. Ebert, Jean Anderson Eloy, Carrie E. Flanagan, Wytske J. Fokkens, Christine Franzese, Jan Gosepath, Ashleigh Halderman, Robert G. Hamilton, Hans Jürgen Hoffman, Jens M. Hohlfeld, Steven M. Houser, Peter H. Hwang, Cristoforo Incorvaia, Deborah Jarvis, Ayesha N. Khalid, Maritta Kilpeläinen, Todd. T. Kingdom, Helene Krouse, Desiree Larenas-Linnemann, Adrienne M. Laury, Stella E. Lee, Joshua M. Levy, Amber U. Luong, Bradley F. Marple, Edward D. McCoul, K. Christopher McMains, Erik Melén, James W. Mims, Gianna Moscato, Joaquim Mullol, Harold S. Nelson, Monica Patadia, Ruby Pawankar, Oliver Pfaar, Michael P. Platt, William Reisacher, Carmen Rondón, Luke Rudmik, Matthew Ryan, Joaquin Sastre, Rodney J. Schlosser, Russell A. Settipane, Hemant P. Sharma, Aziz Sheikh, Timothy L. Smith, Pongsakorn Tantilipikorn, Jody R. Tversky, Maria C. Veling, De Yun Wang, Marit Westman, Magnus Wickman & Mark Zacharek. (2018) International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis. International Forum of Allergy & Rhinology 8:2, pages 108-352.
Crossref
Anne K. Ellis, Lisa M. Steacy, Abhijeet Joshi, Shravanti Bhowmik & Atul Raut. (2016) Efficacy of the novel nasal steroid S0597 tested in an environmental exposure unit. Annals of Allergy, Asthma & Immunology 117:3, pages 310-317.
Crossref
Friedrich Horak, Kamal D. Puri, Bart H. Steiner, Leanne Holes, Guan Xing, Petra Zieglmayer, René Zieglmayer, Patrick Lemell & Albert Yu. (2016) Randomized phase 1 study of the phosphatidylinositol 3-kinase δ inhibitor idelalisib in patients with allergic rhinitis. Journal of Allergy and Clinical Immunology 137:6, pages 1733-1741.
Crossref
Pavol Surda & Wytske J. Fokkens. (2016) Novel, Alternative, and Controversial Therapies of Rhinitis. Immunology and Allergy Clinics of North America 36:2, pages 401-423.
Crossref
Philipp Badorrek, Jens M. Hohlfeld, Norbert Krug, Abhijeet Joshi & Atul Raut. (2015) Efficacy and safety of a novel nasal steroid, S0597, in patients with seasonal allergic rhinitis. Annals of Allergy, Asthma & Immunology 115:4, pages 325-329.e1.
Crossref
R. D. Murdoch, P. Bareille, D. Ignar, S. R. Miller, A. Gupta, R. Boardley, P. Zieglmayer, R. Zieglmayer, P. Lemel & F. Horak. (2015) The improved efficacy of a fixed-dose combination of fluticasone furoate and levocabastine relative to the individual components in the treatment of allergic rhinitis. Clinical & Experimental Allergy 45:8, pages 1346-1355.
Crossref
Hendrik Nolte, Jennifer Maloney, Harold S. Nelson, David I. Bernstein, Susan Lu, Ziliang Li, Amarjot Kaur, Petra Zieglmayer, René Zieglmayer, Patrick Lemell & Friedrich Horak. (2015) Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber. Journal of Allergy and Clinical Immunology 135:6, pages 1494-1501.e6.
Crossref
Michelle L. North, Mena Soliman, Terry Walker, Lisa M. Steacy & Anne K. Ellis. (2015) Controlled Allergen Challenge Facilities and Their Unique Contributions to Allergic Rhinitis Research. Current Allergy and Asthma Reports 15:4.
Crossref
Fulvio Braido, Francesca Sclifò, Matteo Ferrando & Giorgio Walter Canonica. (2014) New Therapies for Allergic Rhinitis. Current Allergy and Asthma Reports 14:4.
Crossref
Katarzyna Rogoz, Helena Haddadi Andersen, Klas Kullander & Malin C. Lagerström. (2014) Glutamate, Substance P, and Calcitonin Gene-Related Peptide Cooperate in Inflammation-Induced Heat Hyperalgesia. Molecular Pharmacology 85:2, pages 322-334.
Crossref
F. Horak, P. Zieglmayer, R. Zieglmayer, P. Lemell, L. P. Collins, M. G. Hunter, J. Steiner, T. Lewis, M. A. Payton, C. M. Perkins & R. Pettipher. (2012) The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial. Allergy, pages n/a-n/a.
Crossref
Lawrence M. DuBuske. (2012) Twenty-Four–hour Duration of Effect of Intranasal Corticosteroids for Seasonal Allergic Rhinitis Symptoms: Clinical Evidence and Relevance. American Journal of Rhinology & Allergy 26:4, pages 287-292.
Crossref
P. Devillier, M. Le Gall & F. Horak. (2011) The allergen challenge chamber: a valuable tool for optimizing the clinical development of pollen immunotherapy. Allergy 66:2, pages 163-169.
Crossref
P. Demoly, J.M. Klossek, É. Serrano & A. Didier. (2010) Efficacité des corticoïdes par voie nasale sur les symptômes oculaires de la rhinite allergique. Revue Française d'Allergologie 50:5, pages 419-425.
Crossref
Friedrich Horak, Petra Zieglmayer, René Zieglmayer, Patrick Lemell, Philippe Devillier, Armelle Montagut, Michel Mélac, Sylvie Galvain, Stéphanie Jean-Alphonse, Laurence Van Overtvelt, Philippe Moingeon & Martine Le Gall. (2009) Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber. Journal of Allergy and Clinical Immunology 124:3, pages 471-477.e1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.